All posts by Pathology Horizons

A conference on what lies ahead for Pathology?

Pathology Horizons Webinar: Registration Now Open!

Registration is now open for our special Pathology Horizons webinar edition. 

As you are aware the usual two day Pathology Horizons conference hosted by Cirdan has been postponed until 2021, but so as you don’t completely miss out we are organising a virtual treat for you this September.

We are excited to formally announce that we will be hosting a special Pathology Horizons webinar edition on Wednesday, 16th September 2020 at 15:00 (BST). This two-hour webinar will be in keeping with our usual Pathology Horizons theme i.e. the future of pathology but will focus particularly on the impact of COVID-19 for pathology and laboratory medicine.

We have brought together a range of expert international panellists from different backgrounds who will discuss:

  • How the COVID-19 pandemic has affected them?
  • What impact it will have on the future of pathology and laboratory medicine?
  • How the industry can best prepare for what lies ahead.

There will be an opportunity to put questions to the panel and some time for discussion.

Some of these well-known industry experts are due to speak at the Pathology Horizons 2021 conference in Newcastle, N. Ireland next year (9th-11th September 2021). So, the webinar will provide a sneak peek into the speaker calibre that you can expect to hear next year.

For more information on the backgrounds of our webinar panellists above visit the Pathology Horizons website here.

We look forward to welcoming you to what we hope will be an excellent virtual learning experience. 

Stay safe,
Team Cirdan

PS – There will not be a registration fee to join the webinar.

Pathology Horizons: Watch And Learn

It is at a time like this when we really appreciate the work and developments that are taking place within the world of pathology and laboratory medicine. We realise just how much we depend on the pathologists and laboratory professionals for scientific answers and medical findings that are integral to many clinical decisions within healthcare organisations.

Recently, we have been looking back at speaker videos from Pathology Horizons conferences through the years and it’s amazing to see how many of these ideas are now a reality within laboratory operations. We are privileged to have had leading industry experts from across the world attend and speak at Pathology Horizons. The speakers have provided us with insightful knowledge on groundbreaking topics relating to new and emerging techniques, procedures and technologies that are driving the future of pathology.

We would like share some of these videos with you, beginning with a presentation on Computational Pathology by Dr. Liron Pantanowitz from University of Pittsburgh, USA which took place at Pathology Horizons 2017 in the beautiful Cairns, Australia. Dr. Pantanowitz is a well known Professor in the field of Pathology and Bioinformatics and is the Director of the Pathology Informatics Division at the University of Pittsburgh Medical Center (UPMC).

The presentation covers the pros and cons of computer aided diagnosis within Pathology and emphasises what is required to develop these much awaited applications. Can AI truly become a reality within Pathology? Can these deep learning tools perform the complex tasks of pathologists, and in some instances with superior accuracy?

View full presentation:

Dr. Liron Pantanowitz – Computer Aided Diagnosis in Pathology: Pros & Cons

Pathology Horizons Postponed Until 2021

An update from Elaine Armstrong, Head of Marketing at Cirdan & Pathology Horizons Organiser:

It is with a heavy heart that we have decided to postpone this year’s Pathology Horizons conference as a result of the uncertainty around the COVID-19 pandemic and the international travel restrictions in place.

However, we are pleased to inform you that a new date for the conference has been confirmed. It will now take place from 9th to 11th September 2021 in the same venue – The Slieve Donard Resort & Spa, Newcastle, N.Ireland.

We hope that you are able join us next year for Pathology Horizons 2021. In the meantime… keep your eye out for news on some interesting virtual Pathology Horizons learning opportunities later this year.

Keep up-to-date with the 2021 conference at www.pathologyhorizons.com and via our social media platforms below.

If you have any queries relating to Pathology Horizons or if we can do anything to support your lab at this time please contact me directly at earmstrong@cirdan.com.

Stay safe and take care,

Elaine Armstrong
Head of Marketing at Cirdan & Pathology Horizons Organiser

Pathology Horizons 2020: Covid-19 Update

We are pleased to announce that the Pathology Horizons 2020 conference is going ahead as planned in Newcastle, Northern Ireland from 10-12 September. 

Due to the uncertainty around the COVID-19 pandemic we have postponed the opening of Early Bird registration. We will keep you informed of when we plan to open this. We are hopeful that we will all be in a better place by September.

If anything changes we will update you as soon as possible.To ensure that you receive all communications about the conference please make sure that you pre-register.

Pathology Horizons

Pathology Horizons is an annual and open CPD conference organised by Cirdan to discuss what developments lie ahead in Pathology and what we can do to prepare or take advantage of these. 

This year the conference will take place in the beautiful Slieve Donard Resort & Spa located in the seaside town of Newcastle in N. Ireland. Nestling at the foot of the Mountains of Mourne, the Resort stands in six acres of immaculate private grounds. A golden strand of beach borders one side while the mighty Royal County Down Golf Links frames the other.  Located just 30 miles south of Belfast and 90 miles north of Dublin, it is a fantastic location to mix pleasure and business at this year’s pathology Horizons event. 

“It is truly unique in the way that you support innovation, this kind of conference does not exist anywhere else… you showcase all the good and new things that are coming in pathology. Top organisation and very good speakers!”

Dr. Laszlo Igali
Norfolk and Norwich University Hospitals NHS

Registration

If you would like to be notified when Pathology Horizons 2020 registration opens, please click here.

Dr. Jo Horne to Speak At Pathology Horizons 2020

We are delighted to announce that Dr. Jo Horne of University Hospital Southampton NHS will speak at Pathology Horizons 2020.

About Dr. Jo Horne

Jo is an Advanced Practitioner in Histopathology at University Hospital Southampton NHS Foundation Trust, specialising in gastrointestinal and hepatobiliary histopathology. She is dual registered with the HCPC as a Biomedical Scientist and Clinical Scientist, and is an IBMS Fellow and Diplomate Member of the RCPath. Jo was awarded a national CSO WISE Fellowship in 2017, which is a national leadership programme for women in Healthcare Science, and she won the Advancing Healthcare Awards national Biomedical Scientist of the Year award in 2019.

Jo was one of the original pilot participants in the UK national histopathology reporting diploma programme, completing her training in 2017.  Since then she has been working as part of the consultant specialty team at Southampton, independently dissecting and reporting gastrointestinal specimens, representing the department at MDT meetings and participating in research and audit. 

Jo is a national member of the IBMS council, and also sits on the conjoint boards for both the histological dissection and reporting qualifications, and with the National School of Healthcare Science as an examiner for the national STP training programme, and as lead editor for the histopathology STP curriculum review.  Jo is part of a national working group reviewing training pathways within histopathology for Healthcare Scientists, and is passionate about the development and promotion of advanced careers for all Healthcare Scientists working within Pathology.

Pathology Horizons 2020

Pathology Horizons is an annual and open CPD conference organised by Cirdan to discuss what developments lie ahead in Pathology and what we can do to prepare or take advantage of these. 

This year the conference will take place from 10 – 12 September in the beautiful Slieve Donard Resort & Spa located in the seaside town of Newcastle in N. Ireland. Nestling at the foot of the Mountains of Mourne, the Resort stands in six acres of immaculate private grounds. A golden strand of beach borders one side while the mighty Royal County Down Golf Links frames the other.  Located just 30 miles south of Belfast and 90 miles north of Dublin, it is a fantastic location to mix pleasure and business at this year’s Pathology Horizons event. 

If you would like to be notified when Pathology Horizons 2020 registration opens, please click here.

 

Dr. Eric Glassy to Return to Pathology Horizons

Back by popular demand, keynote speaker, Dr. Eric Glassy from Providence Little Company of Mary Medical Center, USA will present this September at Pathology Horizons 2020 in N. Ireland.

About Dr. Glassy

Dr. Glassy is a community pathologist in Southern California and director of pathology at Providence Little Company of Mary Medical Center, San Pedro, California. He is a member of Affiliated Pathologists Medical Group, a 40 person independent pathology group covering 15 hospitals and laboratories in California, Portland and Phoenix. He has chaired hospital and CAP national committees. He has served as chairman of the Hematology, Publications, Digital Pathology, Curriculum, and Information Technology Leadership Committees.

He has been involved with digital pathology for over 10 years and has lectured at major pathology conferences such as USCAP, CAP, ASCP, Pathology Visions, and the Royal College of Pathologists. He is past president of the Digital Pathology Association. He edited and illustrated several pathology color atlases and developed software programs for pathology reporting, outreach, and practice management. He holds a green belt in Six Sigma. He is a trustee of the American Board of Pathology as well as a governor of the College of American Pathologists.

View talk from Pathology Horizons 2018 by Dr. Glassy: “Extreme Makeover: Creating Pathology Reports that Make a Difference.”

Pathology Horizons 2020

Pathology Horizons is an annual and open CPD conference organised by Cirdan to discuss what developments lie ahead in Pathology and what we can do to prepare or take advantage of these. 

 

This year the conference will take place on 10 – 12 September in the beautiful Slieve Donard Resort & Spa located in the seaside town of Newcastle in N. Ireland. Nestling at the foot of the Mountains of Mourne, the Resort stands in six acres of immaculate private grounds. A golden strand of beach borders one side while the mighty Royal County Down Golf Links frames the other.  Located just 30 miles south of Belfast and 90 miles north of Dublin, it is a fantastic location to mix pleasure and business at this year’s pathology Horizons event. 

If you would like to be notified when Pathology Horizons 2020 registration opens, please click here.

Pathology Horizons 2020: The Big Reveal!

“Where the Mountains of Mourne sweep down to the sea…….”

We are excited to announce that Pathology Horizons 2020 will take place at the beautiful Slieve Donard Resort & Spa located in Newcastle, County Down in Northern Ireland. 2020 will be a special year for Cirdan as it will see the organisation celebrate its 10 year anniversary. It was with this celebration in mind that we decided to host our sixth Pathology Horizons conference in Northern Ireland, not far from where the company started back in 2010. 

Nestling at the foot of the Mourne Mountains, this Victorian hotel stands in six acres of immaculate private grounds. A golden strand of beach borders one side while the mighty Royal County Down Golf Links frames the other. It is located just 30 miles south of Belfast and 90 miles north of Dublin, making it very accessible from both airports on the island of Ireland.

Why attend?

This unique conference brings together a panel of expert international speakers to discuss the future of pathology. It provides the opportunity to learn about new technologies, procedural developments and lines of research that are driving the future of pathology and laboratory medicine. Learning is done in a relaxed and fun environment, where all attendees are able to network freely with each other. This combined with the boutique nature of the event make it a conference like no other.

Who should attend?

Pathology Horizons is open to anyone interested in the area of pathology and laboratory medicine e.g. Pathologists, Laboratory Professionals, Laboratory Technicians,  Biomedical Scientists and Pathology IT staff.

Early Bird Registration

Early Bird registration has not yet been opened, but it is possible to pre-register at this stage. **Please note: Due to the boutique nature of the conference places are limited, so if you would like to attend please remember to book early to avoid disappointment.**

Pre-register

If you would like to be notified of when early bird registration opens, click the button below.

Artificial Intelligence and Computational Pathology: Implications for Precision Medicine

With the advent of digital pathology, there is an opportunity to develop computerized image analysis methods to not just detect and diagnose disease from histopathology tissue sections, but to also attempt to predict risk of recurrence, predict disease aggressiveness and long term survival. At the Center for Computational Imaging and Personalized Diagnostics, our team has been developing a suite of image processing and computer vision tools, specifically designed to predict disease progression and response to therapy via the extraction and analysis of image-based “histological biomarkers” derived from digitized tissue biopsy specimens. These tools would serve as an attractive alternative to molecular based assays, which attempt to perform the same predictions.

The fundamental hypotheses underlying our work are that: 1) the genomic expressions detected by molecular assays manifest as unique phenotypic alterations (i.e. histological biomarkers) visible in the tissue; 2) these histological biomarkers contain information necessary to predict disease progression and response to therapy; and 3) sophisticated computer vision algorithms are integral to the successful identification and extraction of these biomarkers. We have developed and applied these prognostic tools in the context of several different disease domains including ER+ breast cancer, prostate cancer, Her2+ breast cancer, ovarian cancer, and more recently medulloblastomas. For the purposes of this talk Dr. Madabhushi will focus on their work in breast, prostate, rectal, oropharyngeal, and lung cancer.

About Dr. Anant Madabhushi

Dr. Madabhushi is the Director of the Center for Computational Imaging and Personalized Diagnostics (CCIPD). He is also the F. Alex Nason Professor II in the Departments of Biomedical Engineering, Pathology, Radiology, Radiation Oncology, Urology, General Medical Sciences, and Electrical Engineering and Computer Science at Case Western Reserve University.

Madabhushi received his Bachelors Degree in Biomedical Engineering from Mumbai University, India in 1998 and his Masters in Biomedical Engineering from the University of Texas, Austin in 2000. In 2004 he obtained his PhD in Bioengineering from the University of Pennsylvania and joined the Department of Biomedical Engineering, Rutgers University as an Assistant Professor in 2005. He was promoted to Associate Professor with Tenure in 2010. In 2012 he accepted the position of Associate Professor at Case Western Reserve University, Department of Biomedical Engineering and is currently directing a center on computational imaging and personalized diagnostics. He was promoted to full professor in 2014.

Dr. Madabhushi has authored over 150 peer-reviewed journal publications  and over 180 conferences papers and delivered over 240 invited talks and lectures both in the US and abroad. He has over 75 patents either issued or pending in the areas of medical image analysis, computer-aided diagnosis, and computer vision.  He has been the recipient of a number of awards for both research as well as teaching, including the Department of Defense New Investigator Award in Lung Cancer (2014), the Coulter Phase 1 and Phase 2 Early Career award (2006, 2008), and the Excellence in Teaching Award (2007-2009), along with a number of technology commercialization awards.  His research work has received grant funding from the National Cancer Institute (NIH), National Science Foundation, the Department of Defense, private foundations, and from Industry. 

Pathology Horizons 2019

Pathology Horizons is an annual and open CPD event organised by Cirdan to discuss what developments lie ahead in Pathology and what we can do to prepare or take advantage of these. Dr. Harewood will be joined by 13 more international industry experts with some of the topics including:

  • FHIR: transforming the pathology business relationship
  • Cancer Immunotherapy Biomarker
  • Digital Pathology
  • Light-sheet Microscopy
  • Machine Learning in Pathology
  • ctDNA testing for cancer

**Given the boutique nature of this conference places are limited, so please book early to guarantee your place.** Find out more about the speakers, agenda and registration here.

Dr. Louise Harewood to Speak on Cancer Genomics at Pathology Horizons 2019

Dr. Louise Harewood is the Scientific Lead for the Genomics division of the Precision Medicine Centre (PMC) in Belfast, Northern Ireland. The PMC is a new clinical laboratory that brings together high-throughput genomics, digital pathology and big data analytics in a fully integrated fashion. The aim of the centre is to accelerate the translation of potentially relevant diagnostic, prognostic and therapeutic findings into clinically actionable information by applying state-of-the-art technology in a clinical laboratory environment.

Louise has a strong genomics background, based largely around structural rearrangement and copy number variation detection, 3D nuclear organisation and genome regulation. Before joining the PMC, she held a position as an independent postdoc in the Innovation lab at the Cancer Research UK Cambridge Institute, a post created for her to enable continuation of a previous postdoc project and to bring in and develop new techniques within the building.

Talk Title: Cancer Genomics: A Precision Medicine Centre Perspective

Genomic abnormalities play a pivotal role in cancer diagnostics and prognostics, as well as helping to guide treatment choices for individual patients. Although genomic techniques to detect single gene mutations have long since been established in the clinical diagnostic workflow, many other actionable or diagnostic abnormalities, such as structural or copy number variants, continue to be detected by other methods (e.g. FISH, array based methods or cytogenetics) with many different tests often being required for a single patient.

Whilst genomic sequencing techniques, such as whole genome sequencing, can provide all of this information, they have historically been hindered by high costs, long turnaround times and a lack of suitable bioinformatic analysis tools. This, however, is rapidly changing:  – per base sequencing costs have dramatically reduced and sequencing has entered the realms of affordability for many clinical labs. Library preparation and sequencing protocols continue to be improved and made more amenable to automation. There are also a host of computational analysis tools now available on the market with others being continually developed.

The time is approaching when large-scale genomic analyses will be able to replace the multiple individual tests that are currently undertaken for clinical diagnostic purposes in many labs. The generated data will not only allow treatment to be more accurately tailored to individual patients, but also provide vital information about cancer subtypes, risk stratification and provide a vast collection of data that can be re-mined as new biomarkers are discovered.

In this talk, Dr. Harewood will discuss some of the approaches that they are investigating within the PMC with the aim of bringing new genomic technologies into the clinical diagnostic field.

Pathology Horizons 2019

Pathology Horizons is an annual and open CPD event organised by Cirdan to discuss what developments lie ahead in Pathology and what we can do to prepare or take advantage of these. Dr. Harewood will be joined by 13 more international industry experts with some of the topics including:

  • FHIR: transforming the pathology business relationship
  • Cancer Immunotherapy Biomarker
  • Digital Pathology
  • Light-sheet Microscopy
  • Machine Learning in Pathology
  • ctDNA testing for cancer

**Given the boutique nature of this conference places are limited, so please book early to guarantee your place.** Find out more about the speakers, agenda and registration here.

This image has an empty alt attribute; its file name is Register.png

Clinical metagenomics – are we there yet?

The use of metagenomic sequencing is becoming well-known in human microbiome testing. As high-throughput sequencing becomes more readily available and cost is lowering, more medical testing laboratories are considering the clinical use of shotgun metagenomics.

Clinical applications include identification of infectious agents directly from specimens, including when pathogens are not readily detected using conventional diagnostics. The diagnosis of systemic and central nervous system infections are examples of breakthroughs that have been described. In addition to pathogen identification and microbiome analysis, metagenomics can also be used to explore potential antimicrobial resistance. Clinical metagenomics can assist with therapeutic decision-making, as well as infection prevention and control. Understanding the benefits and barriers in the context of the clinical application is necessary to ensure safe clinical practice and determine regulatory compliance.  

In this presentation, Schlebusch will decode and explore the use of metagenomics in clinical practice.

 About  Dr. Schlebusch

 Dr. Schlebusch is an experienced clinical microbiologist recognised for her research, expertise and implementation of innovative technologies for diagnosis of infectious diseases and antimicrobial resistance. She has been the Director of Microbiology at Mater Pathology in Brisbane for the last 7 years. She has recently been appointed as Staff Specialist at Forensic and Scientific Services, Health Support Queensland. Forensic and Scientific Services is Queensland’s reference laboratory for notifiable conditions and routinely performs whole genome sequencing for disease surveillance, disease outbreaks and research.

Pathology Horizons | 8-10th August 2019

Dr. Schlebusch will present on Clinical Metagenomics at the Pathology Horizons conference  in Queenstown, New Zealand. 

The conference is an annual and open CPD event organised by Cirdan to discuss what developments lie ahead in Pathology and what we can do to prepare or take advantage of these. Dr. Schlebusch will be joined by 13 more international industry experts with some of the topics including:

  • FHIR: transforming the pathology business relationship
  • Cancer Immunotherapy Biomarker
  • Digital Pathology
  • Light-sheet Microscopy
  • Machine Learning in Pathology
  • ctDNA testing for cancer

Learn more and register.

**Given the boutique nature of this conference places are limited, so please book early to guarantee your place.**